ZIM Laboratories Limited (ZIMLAB.BO)
INR 85.47
(-0.13%)
INR 85.47
(-0.13%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 983.6 Million INR | 76.97% |
| 2022 | 555.79 Million INR | 11.4% |
| 2021 | 498.93 Million INR | -38.35% |
| 2020 | 809.27 Million INR | -10.56% |
| 2019 | 904.85 Million INR | 17.97% |
| 2018 | 767.05 Million INR | -3.73% |
| 2017 | 796.77 Million INR | -0.57% |
| 2016 | 801.34 Million INR | -15.85% |
| 2015 | 952.25 Million INR | 3.43% |
| 2014 | 920.67 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 FY | 983.6 Million INR | 76.97% |
| 2023 Q4 | 983.6 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 469.68 Million INR | 0.0% |
| 2022 Q4 | 555.79 Million INR | 0.0% |
| 2022 FY | 555.79 Million INR | 11.4% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 583.89 Million INR | 0.0% |
| 2021 Q2 | 850.52 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 498.93 Million INR | 0.0% |
| 2021 FY | 498.93 Million INR | -38.35% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 809.27 Million INR | 0.0% |
| 2020 Q2 | 619.34 Million INR | 0.0% |
| 2020 FY | 809.27 Million INR | -10.56% |
| 2019 Q4 | 904.85 Million INR | 0.0% |
| 2019 Q2 | 766.82 Million INR | 0.0% |
| 2019 FY | 904.85 Million INR | 17.97% |
| 2018 FY | 767.05 Million INR | -3.73% |
| 2018 Q4 | 767.05 Million INR | 0.0% |
| 2018 Q2 | 701.04 Million INR | 0.0% |
| 2017 Q4 | 796.77 Million INR | 0.0% |
| 2017 FY | 796.77 Million INR | -0.57% |
| 2016 FY | 801.34 Million INR | -15.85% |
| 2015 FY | 952.25 Million INR | 3.43% |
| 2014 FY | 920.67 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 74.557% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 73.368% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 134.602% |
| Granules India Limited | 9.28 Billion INR | 89.409% |
| Indoco Remedies Limited | 6.47 Billion INR | 84.812% |
| Achyut Healthcare Limited | -3.74 Million INR | 26357.448% |
| Ajanta Pharma Limited | -954.9 Million INR | 203.006% |
| Alkem Laboratories Limited | -1.6 Billion INR | 161.116% |
| Alpa Laboratories Limited | 35.36 Million INR | -2681.45% |
| Brooks Laboratories Limited | 49.48 Million INR | -1887.681% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 119.623% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 70.184% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 184.958% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 92.383% |
| Eris Lifesciences Limited | 13.8 Billion INR | 92.876% |
| FDC Limited | -57.75 Million INR | 1803.151% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 122.953% |
| Gufic Biosciences Limited | 3.19 Billion INR | 69.208% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 123.684% |
| Ipca Laboratories Limited | 11.41 Billion INR | 91.383% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 170.766% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 49.113% |
| Lasa Supergenerics Limited | 205.79 Million INR | -377.944% |
| Laurus Labs Limited | 24.38 Billion INR | 95.966% |
| Lupin Limited | 17.19 Billion INR | 94.279% |
| Mankind Pharma Limited | -9.9 Billion INR | 109.927% |
| Medicamen Biotech Limited | 160.31 Million INR | -513.541% |
| Medico Remedies Limited | 78.67 Million INR | -1150.18% |
| Megasoft Limited | 1.28 Billion INR | 23.488% |
| NATCO Pharma Limited | -5.81 Billion INR | 116.909% |
| Piramal Pharma Limited | 42.27 Billion INR | 97.673% |
| RPG Life Sciences Limited | -364.7 Million INR | 369.702% |
| Sigachi Industries Limited | 859.94 Million INR | -14.379% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 101.357% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -578.46% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -2028.506% |
| Unichem Laboratories Limited | 931.91 Million INR | -5.546% |
| Wanbury Limited | 1.1 Billion INR | 11.056% |
| Windlas Biotech Limited | -273.04 Million INR | 460.242% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 74.857% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 204.439% |
| Divi's Laboratories Limited | -39.77 Billion INR | 102.473% |
| Hester Biosciences Limited | 2.29 Billion INR | 57.062% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 141.891% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 495.352% |
| Bal Pharma Limited | 1.26 Billion INR | 22.156% |
| Strides Pharma Science Limited | 23.25 Billion INR | 95.771% |
| Venus Remedies Limited | -267.7 Million INR | 467.428% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | 62.341% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 84.025% |
| Shilpa Medicare Limited | 9.06 Billion INR | 89.155% |
| Aarti Drugs Limited | 5.54 Billion INR | 82.272% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 189.313% |
| Suven Life Sciences Limited | -1.63 Billion INR | 160.244% |
| Ind-Swift Limited | 9.5 Billion INR | 89.656% |
| Valiant Laboratories Limited | -295.03 Million INR | 433.389% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 65.135% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | 90.192% |
| Themis Medicare Limited | 764.96 Million INR | -28.582% |
| Hikal Limited | 7.96 Billion INR | 87.654% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 96.91% |
| Sequent Scientific Limited | 4.17 Billion INR | 76.461% |
| Novartis India Limited | -5.89 Billion INR | 116.696% |
| Wockhardt Limited | 18.27 Billion INR | 94.616% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 96.367% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 5432.343% |
| Neuland Laboratories Limited | -214.05 Million INR | 559.503% |
| Morepen Laboratories Limited | -231.17 Million INR | 525.482% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -719.404% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -0.799% |